CareCloud (CCLD) AI Stock Analysis

• Market Cap: $121.89M
• Dividend Yield: N/A
• Average Volume (3M): 364.70K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.54
• Revenue Growth: 2.97%
• EPS Growth: N/A
• Country: US
• Employees: 3,650
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.04
• Shares Outstanding: 42,322,040
• 10 Day Avg. Volume: 292,925
• 30 Day Avg. Volume: 364,701
• PEG Ratio: -0.08
• Price to Book (P/B): 1.19
• Price to Sales (P/S): 0.53
• P/FCF Ratio: 3.12
• Enterprise Value/Market Cap: 0.76
• Enterprise Value/Revenue: 0.81
• Enterprise Value/Gross Profit: 2.42
• Enterprise Value/Ebitda: 3.84
• 1Y Price Target: $6.00
• Price Target Upside: 99.34% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: $3.50 ▲(16.28% Upside)

CareCloud's overall stock score is driven by a stable financial position and positive earnings call results, highlighting revenue growth and strategic initiatives. However, the negative P/E ratio and lack of dividend yield weigh down the valuation score. Technical indicators show moderate strength, contributing to a balanced outlook.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term financial stability.

Strategic Acquisitions

These acquisitions expand CareCloud's market reach and enhance its service offerings, providing competitive advantages in the healthcare sector.

AI Capabilities

Advancements in AI improve operational efficiency and customer service, positioning CareCloud as a leader in healthcare technology innovation.

Negative Factors

Debt from Acquisition

Increased debt from acquisitions can strain financial resources, potentially impacting future investment and growth opportunities.

Declining Profit Margins

Declining profit margins may indicate rising costs or pricing pressures, which could affect long-term profitability and competitiveness.

Negative Revenue Growth

Negative revenue growth suggests challenges in market expansion or product adoption, potentially hindering future financial performance.

CareCloud Business Overview & Revenue Model

Company Description

CareCloud (CCLD) is a leading provider of cloud-based healthcare solutions that cater to medical practices and healthcare organizations. The company operates primarily in the healthcare technology sector, offering a suite of products that includes electronic health records (EHR), practice management, revenue cycle management, and telehealth services. CareCloud's innovative platform is designed to streamline operations, enhance patient engagement, and improve overall healthcare delivery for its clients.

How the Company Makes Money

CareCloud generates revenue through a subscription-based model for its software services, which includes recurring fees for the use of its EHR and practice management solutions. Additionally, the company earns revenue from consulting services, implementation fees, and ongoing support services. Key revenue streams also include transaction-based fees from its revenue cycle management services, which are contingent on the volume of claims processed. Strategic partnerships with healthcare providers and technology companies further bolster its earnings, allowing CareCloud to expand its market reach and enhance service offerings.

CareCloud Financial Statement Overview

Summary

CareCloud demonstrates a stable financial position with strong cash flow and a solid balance sheet. Despite challenges in revenue growth, improvements in profitability and operational efficiency are positive signs. The low leverage and strong cash flow position provide a buffer against potential risks.

Income Statement

CareCloud's income statement shows mixed results. The TTM (Trailing-Twelve-Months) data indicates a gross profit margin of 23.58% and a net profit margin of 10.08%, which are decent but have declined from previous periods. Revenue growth is negative, indicating a contraction in sales. However, the company has managed to improve its net income and EBIT margins compared to the previous year, showing some operational efficiency improvements.

Balance Sheet

The balance sheet is relatively strong with a low debt-to-equity ratio of 0.06, indicating low leverage and financial stability. The return on equity (ROE) is healthy at 21.82%, reflecting good profitability relative to shareholder equity. The equity ratio is also strong, suggesting a solid capital structure.

Cash Flow

Cash flow analysis reveals positive trends, with a significant growth in free cash flow and a strong operating cash flow to net income ratio of 1.53. The free cash flow to net income ratio is also robust at 0.92, indicating efficient cash generation relative to net income. This suggests good liquidity and cash management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	114.31M	110.84M	117.06M	138.83M	139.60M	105.12M
Gross Profit	38.30M	49.99M	46.24M	54.39M	52.68M	40.30M
EBITDA	24.19M	25.05M	-31.29M	21.02M	19.70M	4.80M
Net Income	9.84M	7.85M	-48.67M	5.43M	2.84M	-8.81M
Balance Sheet
Total Assets	90.58M	71.61M	77.83M	136.17M	140.85M	138.00M
Cash, Cash Equivalents and Short-Term Investments	4.26M	5.14M	3.33M	12.30M	9.34M	20.93M
Total Debt	9.67M	3.47M	14.73M	13.81M	16.87M	11.47M
Total Liabilities	32.77M	21.84M	36.11M	34.48M	42.92M	36.75M
Stockholders Equity	57.80M	49.77M	41.72M	101.69M	97.93M	101.25M
Cash Flow
Free Cash Flow	22.39M	18.95M	3.85M	9.38M	2.77M	-8.64M
Operating Cash Flow	25.11M	20.64M	15.46M	21.15M	13.33M	-892.00K
Investing Cash Flow	-23.46M	-7.41M	-11.61M	-11.77M	-23.15M	-31.47M
Financing Cash Flow	648.00K	-11.26M	-13.29M	-7.65M	-519.00K	33.42M

CareCloud Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3.01
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCLD, the sentiment is Positive. The current price of 3.01 is below the 20-day moving average (MA) of 3.16, below the 50-day MA of 3.35, and above the 200-day MA of 2.63, indicating a bullish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 59.01 is Neutral, neither overbought nor oversold. The STOCH value of 51.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CCLD.

CareCloud Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CCLD	66 Neutral	$121.89M	―	21.49%	―	2.97%	―
FORA	56 Neutral	$70.31M	-77.66	-3.20%	―	22.87%	-152.62%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AMWL	45 Neutral	$81.57M	―	-38.35%	―	4.33%	50.50%
BEAT	34 Underperform	$56.61M	-2.37	-315.70%	―	―	-9.13%

CareCloud Corporate Events

CareCloud’s Strong Q3 2025 Results and Growth Outlook

CareCloud, Inc., a prominent player in healthcare technology and generative AI solutions, offers innovative services to enhance financial and operational performance in the healthcare sector. The company recently reported strong third-quarter results for 2025, showcasing a 9% year-over-year revenue increase and marking its sixth consecutive quarter of positive GAAP net income. CareCloud has also raised its full-year revenue guidance, reflecting its strategic growth initiatives, including the successful acquisition of Medsphere and the acceleration of its AI initiatives.

CareCloud Reports Strong Q3 2025 Financial Results

On November 6, 2025, CareCloud announced its third-quarter 2025 financial results, reporting a 9% year-over-year revenue increase and its sixth consecutive quarter of positive GAAP net income. The company raised its full-year revenue guidance to $117-$119 million, driven by successful acquisitions and AI initiatives, positioning itself as a growing leader in the healthcare technology sector.

The most recent analyst rating on (CCLD) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.

CareCloud Declares Dividends for Preferred Stock

On October 7, 2025, CareCloud announced that its Board of Directors declared monthly cash dividends for its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock for October, November, and December 2025. This decision reflects the company’s commitment to providing consistent returns to its shareholders, despite the recent mandatory conversion of Series A Preferred Stock into common stock and its subsequent delisting from Nasdaq. The dividends are part of CareCloud’s strategy to maintain shareholder value and confidence in its financial stability.

The most recent analyst rating on (CCLD) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.

CareCloud Secures $10M Credit Facility from Provident Bank

On September 3, 2025, CareCloud, Inc. secured a $10 million credit facility from Provident Bank, replacing a previous obligation to Wells Fargo. This move, which involved borrowing $8.3 million to support the acquisition of Medsphere Systems Corp., provides more favorable terms and strengthens CareCloud’s liquidity, enhancing its ability to execute its growth strategy.

The most recent analyst rating on (CCLD) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.

CareCloud Completes Acquisition of Medsphere Systems

On August 22, 2025, CareCloud, Inc. completed the acquisition of Medsphere Systems Corporation, a provider of inpatient and ambulatory solutions, thereby expanding its reach into the hospital IT market. This strategic acquisition is expected to offer affordable, scalable solutions to small and mid-sized hospitals, enhancing CareCloud’s position in the healthcare industry by integrating Medsphere’s technology with its AI capabilities to improve patient care and operational efficiency.

The most recent analyst rating on (CCLD) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.